Page last updated: 2024-10-16

gamma-aminobutyric acid and Central Nervous System Lyme Disease

gamma-aminobutyric acid has been researched along with Central Nervous System Lyme Disease in 2 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research Excerpts

ExcerptRelevanceReference
"Chronic neuropathic pain occurs in 10-15% of patients with neuroborreliosis and is difficult to treat."2.71Gabapentin for the symptomatic treatment of chronic neuropathic pain in patients with late-stage lyme borreliosis: a pilot study. ( Hofmann, H; Ring, J; Weissenbacher, S, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Misery, L1
Weissenbacher, S1
Ring, J1
Hofmann, H1

Trials

1 trial available for gamma-aminobutyric acid and Central Nervous System Lyme Disease

ArticleYear
Gabapentin for the symptomatic treatment of chronic neuropathic pain in patients with late-stage lyme borreliosis: a pilot study.
    Dermatology (Basel, Switzerland), 2005, Volume: 211, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Amines; Chronic Disease; Cyclohexanecarboxylic Acids;

2005

Other Studies

1 other study available for gamma-aminobutyric acid and Central Nervous System Lyme Disease

ArticleYear
Gabapentin in dermatology.
    Dermatology (Basel, Switzerland), 2005, Volume: 211, Issue:2

    Topics: Amines; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lyme Neuro

2005